Rebecca Ceder
Overview
Explore the profile of Rebecca Ceder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antonsen S, Amundsen E, Ceder R, Toska K, Tollanes M, Hansen Y, et al.
EJIFCC
. 2024 Nov;
35(3):154-165.
PMID: 39507572
Electronic exchange of health care data demands code/terminology systems. In the Scandinavian countries, the IFCC-IUPAC's Nomenclature for Properties and Units (NPU) terminology is used for results in biochemistry, pharmacology, and...
2.
Petersen U, Padro-Miquel A, Taylor G, Hertz J, Ceder R, Fuentes-Arderiu X, et al.
Clin Chim Acta
. 2018 May;
484:122-131.
PMID: 29777667
This document describes the application of the syntax, semantic rules, and format of the Nomenclature for Properties and Units (NPU) terminology for coded dedicated kinds-of-property in the subject field of...
3.
Kohonen P, Parkkinen J, Willighagen E, Ceder R, Wennerberg K, Kaski S, et al.
Nat Commun
. 2017 Jul;
8:15932.
PMID: 28671182
Predicting unanticipated harmful effects of chemicals and drug molecules is a difficult and costly task. Here we utilize a 'big data compacting and data fusion'-concept to capture diverse adverse outcomes...
4.
Kohonen P, Benfenati E, Bower D, Ceder R, Crump M, Cross K, et al.
Mol Inform
. 2016 Aug;
32(1):47-63.
PMID: 27481023
The aim of the SEURAT-1 (Safety Evaluation Ultimately Replacing Animal Testing-1) research cluster, comprised of seven EU FP7 Health projects co-financed by Cosmetics Europe, is to generate a proof-of-concept to...
5.
Pournara A, Kippler M, Holmlund T, Ceder R, Grafstrom R, Vahter M, et al.
Cell Biol Toxicol
. 2016 May;
32(4):275-84.
PMID: 27165195
Arsenic, an established carcinogen and toxicant, occurs in drinking water and food and affects millions of people worldwide. Arsenic appears to interfere with gene expression through epigenetic processes, such as...
6.
Grafstrom R, Nymark P, Hongisto V, Spjuth O, Ceder R, Willighagen E, et al.
Altern Lab Anim
. 2015 Nov;
43(5):325-32.
PMID: 26551289
This paper outlines the work for which Roland Grafström and Pekka Kohonen were awarded the 2014 Lush Science Prize. The research activities of the Grafström laboratory have, for many years,...
7.
Jerhammar F, Johansson A, Ceder R, Welander J, Jansson A, Grafstrom R, et al.
Oral Oncol
. 2014 Jul;
50(9):832-9.
PMID: 24993889
Objectives: Targeted therapy against the epidermal growth factor receptor (EGFR) only variably represents a therapeutic advance in head and neck squamous cell carcinoma (HNSCC). This study addresses the need of...
8.
Kohonen P, Ceder R, Smit I, Hongisto V, Myatt G, Hardy B, et al.
Basic Clin Pharmacol Toxicol
. 2014 May;
115(1):50-8.
PMID: 24779563
Toxicological research faces the challenge of integrating knowledge from diverse fields and novel technological developments generally in the biological and medical sciences. We discuss herein the fact that the multiple...
9.
Ottosson-Wadlund A, Ceder R, Preta G, Pokrovskaja K, Grafstrom R, Heyman M, et al.
Mol Pharmacol
. 2012 Oct;
83(1):245-55.
PMID: 23093495
Bortezomib is a highly selective inhibitor of the 26S proteasome and has been approved for clinical use in the treatment of relapsing and refractory multiple myeloma and mantle cell lymphoma....
10.
Hansson M, Behmer S, Ceder R, Mohammadi S, Preta G, Grafstrom R, et al.
PLoS One
. 2012 Oct;
7(9):e46001.
PMID: 23029358
Mastermind-like 1 (MAML1) is a transcriptional coregulator of activators in various signaling pathways, such as Notch, p53, myocyte enhancer factor 2C (MEF2C) and beta-catenin. In earlier studies, we demonstrated that...